DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,206,622 | -10.0% | 5,584 | -0.0% | 0.06% | -6.2% |
| Q2 2023 | $1,340,430 | -15.3% | 5,585 | -13.3% | 0.06% | -22.6% |
| Q1 2023 | $1,582,265 | +4.3% | 6,443 | +12.7% | 0.08% | -19.2% |
| Q4 2022 | $1,517,153 | +14.2% | 5,716 | +8.3% | 0.10% | +3.0% |
| Q3 2022 | $1,328,000 | -2.0% | 5,277 | -1.2% | 0.10% | -7.3% |
| Q2 2022 | $1,355,000 | -0.8% | 5,343 | -1.4% | 0.11% | +1.9% |
| Q1 2022 | $1,366,000 | -16.1% | 5,420 | +9.5% | 0.11% | -91.5% |
| Q4 2021 | $1,629,000 | +10.7% | 4,951 | +2.5% | 1.26% | +769.7% |
| Q3 2021 | $1,471,000 | +15.5% | 4,832 | +1.7% | 0.14% | +10.7% |
| Q2 2021 | $1,274,000 | +21.0% | 4,749 | +1.5% | 0.13% | +6.5% |
| Q1 2021 | $1,053,000 | +1.6% | 4,680 | +0.4% | 0.12% | -5.4% |
| Q4 2020 | $1,036,000 | +15.9% | 4,662 | +12.2% | 0.13% | -0.8% |
| Q3 2020 | $894,000 | +16.9% | 4,154 | -4.0% | 0.13% | +7.4% |
| Q2 2020 | $765,000 | +29.0% | 4,327 | +1.1% | 0.12% | +8.9% |
| Q1 2020 | $593,000 | -13.0% | 4,282 | -3.6% | 0.11% | +7.7% |
| Q4 2019 | $682,000 | +7.7% | 4,443 | +1.4% | 0.10% | 0.0% |
| Q3 2019 | $633,000 | +21.7% | 4,381 | +20.4% | 0.10% | +4.0% |
| Q2 2019 | $520,000 | +175.1% | 3,639 | +153.8% | 0.10% | +117.4% |
| Q1 2019 | $189,000 | +36.0% | 1,434 | +6.1% | 0.05% | +27.8% |
| Q4 2018 | $139,000 | -12.0% | 1,351 | -7.0% | 0.04% | 0.0% |
| Q3 2018 | $158,000 | +26.4% | 1,453 | +15.0% | 0.04% | +12.5% |
| Q2 2018 | $125,000 | +20.2% | 1,263 | +18.9% | 0.03% | +10.3% |
| Q1 2018 | $104,000 | -6.3% | 1,062 | -11.4% | 0.03% | -6.5% |
| Q4 2017 | $111,000 | +42.3% | 1,198 | +32.5% | 0.03% | -3.1% |
| Q3 2017 | $78,000 | +32.2% | 904 | +28.8% | 0.03% | +14.3% |
| Q2 2017 | $59,000 | +13.5% | 702 | +16.0% | 0.03% | -3.4% |
| Q1 2017 | $52,000 | -17.5% | 605 | -25.1% | 0.03% | -31.0% |
| Q4 2016 | $63,000 | – | 808 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |